Evidence map›Paper›PMID 38195153›Full record

ArticleBMJ global health2024

Individual journeys to tuberculosis care in Nigeria's private sector during the COVID-19 pandemic.

Charity Oga-Omenka, Lauren Rosapep, Elaine Baruwa, Lavanya Huria, Nathaly Aquilera Vasquez, Bolanle Olusola Faleye, Md Abdullah Heel Kafi, Angelina Sassi, Chimdi Nwosu, Benjamin Johns and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. COVID-19 policies and tuberculosis services in private health sectors of India, Indonesia, and Nigeria.Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Charity Oga-OmenkaSchool of Public Health Sciences, University of Waterloo, Waterloo, Ontario, Canada omenkac@gmail.com.ORCID 0000-0003-0779-570X
Lauren RosapepABT Associates Inc Bethesda, Bethesda, Maryland, USA.
Elaine BaruwaABT Associates Inc Bethesda, Bethesda, Maryland, USA.
Lavanya HuriaMcGill International TB Center, McGill University Health Centre, Montreal, Vendôme, Canada.
Nathaly Aquilera VasquezMcGill International TB Center, McGill University Health Centre, Montreal, Vendôme, Canada.
Bolanle Olusola FaleyeSustaining Health Outcomes through the Private Sector (SHOPS) Plus, Abuja, Nigeria.
Md Abdullah Heel KafiMcGill International TB Center, McGill University Health Centre, Montreal, Vendôme, Canada.
Angelina SassiMcGill International TB Center, McGill University Health Centre, Montreal, Vendôme, Canada.ORCID 0000-0002-5807-6388
Chimdi NwosuVizSight Analytics Inc, Vancouver, British Columbia, Canada.
Benjamin JohnsABT Associates Inc Bethesda, Bethesda, Maryland, USA.
Abdu AdamuSustaining Health Outcomes through the Private Sector (SHOPS) Plus, Abuja, Nigeria.
Obioma Chijioke-AkaniroNational TB & Leprosy Control Program, Abuja, Nigeria.
Chukwuma AnyaikeNational TB & Leprosy Control Program, Abuja, Nigeria.
Madhukar PaiMcGill International TB Center, McGill University Health Centre, Montreal, Vendôme, Canada.ORCID 0000-0003-3667-4536
McGill University Health Centre · CAAfrican Field Epidemiology Network · NGAbt Global (United States) · USUniversity of Waterloo · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPre-COVID-19, individuals with tuberculosis (TB) in Nigeria were often underdiagnosed and untreated. TB services were mostly in the public sector with only 15% of new cases in 2019 reported from the private sector. Reports highlighted challenges in accessing care in the private sector, which accounted for 67% of all initial care-seeking. Our study examined patients' health seeking pathways for TB in Nigeria's private sector and explored any changes to care pathways during COVID-19.

methodsWe conducted 180 cross-sectional surveys and 20 in-depth interviews with individuals having chest symptoms attending 18 high-volume private clinics and hospitals in Kano and Lagos States. Questions focused on sociodemographic characteristics, health-seeking behaviour, and pathways to care during the COVID-19 pandemic. All surveys and interviews were conducted in May 2021.

resultsMost participants were male (111/180), with an average age of 37. Half (96/180) sought healthcare within a week of symptoms, while few (20/180) waited over 2 months. Individuals testing positive for TB had more health-seeking delays, and those testing negative for TB had more provider delays. On average, participants visited two providers in Kano and 1.69 in Lagos, with 61 of 180 in Kano and 48 of 180 in Lagos visiting other providers before the recruitment facility. Private providers were the initial encounters for most participants (60/180 in Kano, 83/180 in Lagos). Most respondents (164/180) experienced short-lived pandemic-related restrictions, affecting access to transportation, and closed facilities.

conclusionsThis study showed a few challenges in accessing TB care, necessitating continued investment in healthcare infrastructure and resources, particularly in the private sector. Understanding the different care pathways and delays in care provides opportunities for targeted interventions to improve deployment of services closer to where patients first seek care.

Indexed as

COVID-19TuberculosisAdultCross-Sectional StudiesFemaleHumansMaleNigeriaPandemicsPrivate SectorCOVID-19health services researchpublic healthtreatmenttuberculosis

Identifiers

PMID38195153
PMCPMC10806899
OpenAlexW4390699857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.